文献速递其他结缔组织病

2020年新冠疫情期间英格兰罕见自身免疫性风湿病患者死亡风险研究

Risk of death among people with rare autoimmune diseases compared with the general population in England during the 2020 COVID-19 pandemic.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

结果显示RAIRD患者年龄标准化死亡率是既往5年同期的1.44倍(95%CI:1.42,1.45),高于普通人群的1.38倍,且从35岁起各年龄别死亡率即高于新冠前水平(普通人群从55岁起升高),女性增幅大于男性。

要点

  • RAIRD患者2020年3-4月年龄标准化死亡率为3669.3/10万人年,是既往5年同期的1.44倍。
  • 普通人群同期年龄标准化死亡率为既往5年同期的1.38倍,RAIRD患者死亡风险升高更明显。
  • RAIRD患者从35岁起各年龄别死亡率即高于新冠前水平,而普通人群从55岁起才升高。

核心结论

  • 新冠疫情期间RAIRD患者全因死亡风险升高幅度大于普通人群,需量化新冠感染与医疗服务中断各自的贡献。

主要发现

  • 2020年3-4月共1815例(1.1%)RAIRD患者死亡,年龄标准化死亡率为3669.3/10万人年(95%CI:3500.4,3838.1)。
  • RAIRD患者年龄标准化死亡率是既往5年同期的1.44倍(95%CI:1.42,1.45),普通人群为1.38倍。
  • RAIRD患者从35岁起各年龄别死亡率高于新冠前水平,普通人群从55岁起升高;女性死亡率增幅大于男性。

临床怎么用

  • 疫情期间应关注RAIRD患者(尤其35岁以上及女性)的死亡风险升高,并评估医疗服务中断的影响。

局限性

  • 病例 ascertainment 阳性预测值为85%,可能存在错分;未区分新冠感染与医疗服务中断对死亡风险的贡献。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To quantify the risk of death among people with rare autoimmune rheumatic diseases (RAIRD) during the UK 2020 COVID-19 pandemic compared with the general population, and compared with their pre-COVID risk. METHODS: We conducted a cohort study in Hospital Episode Statistics for England from 2003 onwards, and linked data from the NHS Personal Demographics Service. We used ONS published data for general population mortality rates. RESULTS: We included 168 691 people with a recorded diagnosis of RAIRD alive on 1 March 2020. Their median age was 61.7 (IQR 41.5-75.4) years, and 118 379 (70.2%) were female. Our case ascertainment methods had a positive predictive value of 85%. A total of 1815 (1.1%) participants died during March and April 2020. The age-standardized mortality rate (ASMR) among people with RAIRD (3669.3; 95% CI: 3500.4, 3838.1 per 100 000 person-years) was 1.44 (95% CI: 1.42, 1.45) times higher than the average ASMR during the same months of the previous 5 years, whereas in the general population of England it was 1.38 times higher. Age-specific mortality rates in people with RAIRD compared with the pre-COVID rates were higher from the age of 35 upwards, whereas in the general population the increased risk began from age 55 upwards. Women had a greater increase in mortality rates during COVID-19 compared with men. CONCLUSION: The risk of all-cause death is more prominently raised during COVID-19 among people with RAIRD than among the general population. We urgently need to quantify how much risk is due to COVID-19 infection and how much is due to disruption to health-care services.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Peach E, Rutter M, Lanyon P, et al. Risk of death among people with rare autoimmune diseases compared with the general population in England during the 2020 COVID-19 pandemic. Rheumatology (Oxford). 2021. PMID: 33271595. doi:10.1093/rheumatology/keaa855

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。